Pembrolizumab plus chemotherapy is changing first-line care for advanced endometrial cancer, with NRG GY018 showing major progression-free survival gains across MMR status.
Blood-Based Tests
Breast Cancer
Cancer Types
Cellular Therapies (e.g., CAR T)
